- Home
- MBOT vs LENZ Comparison
MBOT vs LENZ Comparison
Compare MBOT & LENZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MBOT | LENZ |
|---|---|---|
| Founded | 2010 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Medicinal Chemicals and Botanical Products |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 126.9M | 142.0M |
| IPO Year | 2000 | 2021 |
Fundamental Metrics
Financial Performance| Metric | MBOT | LENZ |
|---|---|---|
| Price | $1.31 | $3.76 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 5 |
| Target Price | $7.50 | ★ $44.00 |
| AVG Volume (30 Days) | 440.0K | ★ 639.1K |
| Earning Date | 05-15-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 60.27 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $116,887.00 | ★ $19,088,000.00 |
| Revenue This Year | N/A | $50.42 |
| Revenue Next Year | $119.77 | $197.16 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.28 | $4.00 |
| 52 Week High | $3.47 | $50.19 |
Technical Indicators
Market Signals| Indicator | MBOT | LENZ |
|---|---|---|
| Relative Strength Index (RSI) | 35.79 | 34.17 |
| Support Level | N/A | N/A |
| Resistance Level | $2.20 | $6.11 |
| Average True Range (ATR) | 0.05 | 0.25 |
| MACD | 0.00 | -0.08 |
| Stochastic Oscillator | 44.04 | 5.05 |
Price Performance
Historical ComparisonAbout MBOT Microbot Medical Inc.
Microbot Medical Inc is a medical device company specializing in the research, design, and development of next-generation robotic endoluminal surgery devices targeting the minimally invasive surgery space. Using its LIBERTY technological platform, the company has developed the LIBERTY Endovascular Robotic Surgical System, a fully disposable robot for various endovascular interventional procedures. The company has a single operating and reportable segment, which is the development of robotic devices for endoluminal surgery.
About LENZ LENZ Therapeutics Inc.
LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products. Its products VIZZ (aceclidine ophthalmic solution) 1.44% is a once-daily eye drop developed to restore clear near vision for up to 10 hours. VIZZ is powered by aceclidine, highlighted by its differentiated mechanism of action as a predominantly pupil-selective miotic that interacts with the iris, with minimal ciliary muscle stimulation.